Skip to search formSkip to main contentSkip to account menu

VivaGel

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2017
Highly Cited
2017
  • C. L. Ventola
  • P & T : a peer-reviewed journal for formulary…
  • 2017
  • Corpus ID: 5566005
Nanomedicine is a relatively new and rapidly evolving field combining nanotechnology with the biomedical and pharmaceutical… 
Highly Cited
2011
Highly Cited
2011
SPL7013 Gel (VivaGel®) is a microbicide in development for prevention of HIV and HSV. This clinical study assessed retention and… 
Highly Cited
2011
Highly Cited
2011
Objectives:The study was designed to assess the safety, adherence, acceptability, and effect on vaginal microflora of 3% SPL7013… 
Highly Cited
2011
Highly Cited
2011
Objective To assess the safety of VivaGel® used vaginally twice daily for 14 days among healthy, sexually-abstinent women, aged… 
Highly Cited
2010
Highly Cited
2010
Objectives: To evaluate safety, tolerability and systemic pharmacokinetics of escalating doses of SPL7013 Gel in healthy women… 
Review
2009
Review
2009
Objectives Dendrimers by virtue of their therapeutic value have recently generated enormous interest among biomedical scientists… 
Review
2007
Review
2007
Microbicides are compounds that applied vaginally or rectally, protect the user from sexually transmitted infections. Although no… 
Review
2005
Review
2005
Starpharma focuses on the use of dendrimers as drugs in their own right, in contrast to dendrimers as drug delivery vehicles or…